Chinook Therapeutics has raised US$65 million in Series A financing. Versant Ventures led the round with participation from Apple Tree Partners and Samsara BioCapital. Based in Seattle and Vancouver, British Columbia, Chinook is a developer of precision medicines for kidney diseases.
Source: Press Release